179 related articles for article (PubMed ID: 37568332)
1. Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren's Syndrome Complicated with Interstitial Lung Disease.
Wei F; Zhang X; Yang S; Geng J; Xie B; Ren Y; Dai H
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568332
[TBL] [Abstract][Full Text] [Related]
2. Increases in tumor markers are associated with primary Sjögren's syndrome-associated interstitial lung disease.
Shi L; Han XL; Guo HX; Wang J; Tang YP; Gao C; Li XF
Ther Adv Chronic Dis; 2020; 11():2040622320944802. PubMed ID: 32843956
[TBL] [Abstract][Full Text] [Related]
3. Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population.
Zheng M; Lou A; Zhang H; Zhu S; Yang M; Lai W
Rheumatol Ther; 2021 Mar; 8(1):517-527. PubMed ID: 33586127
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.
Weng L; Chen Y; Liang T; Lin Y; Liu D; Yu C; Hu Y; Lui W; Liu Y; Chen X; Li Q; Ge S; Ascherman DP; Chen J
Eur J Med Res; 2022 Oct; 27(1):199. PubMed ID: 36217184
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
8. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Krebs von den Lungen-6 and Surfactant Protein-A Levels in the Patients with Interstitial Lung Disease.
Zheng P; Zheng X; Takehiro H; Cheng ZJ; Wang J; Xue M; Lin Q; Huang Z; Huang H; Liao C; Sun B
J Transl Int Med; 2021 Sep; 9(3):212-222. PubMed ID: 34900632
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of chest HRCT and pulmonary function tests in lung-onset primary sjogren's syndrome.
Dong X; Gao Y; Li M; Wang D; Li J; Zhang Y
Immun Inflamm Dis; 2023 Aug; 11(8):e957. PubMed ID: 37647425
[TBL] [Abstract][Full Text] [Related]
11. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
Ma H; Lu J; Song Y; Wang H; Yin S
BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis.
Wang Q; Gao C; Zhang C; Yao M; Liang W; Sun W; Zheng Z
Clin Rheumatol; 2022 Jun; 41(6):1731-1739. PubMed ID: 35138465
[TBL] [Abstract][Full Text] [Related]
13. Respiratory infection risk in primary Sjögren's syndrome complicated with interstitial lung disease: a retrospective study.
Zhou X; Li H; Wang N; Jin Y; He J
Clin Rheumatol; 2024 Feb; 43(2):707-715. PubMed ID: 38091126
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
[TBL] [Abstract][Full Text] [Related]
15. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.
Fathi M; Barbasso Helmers S; Lundberg IE
J Intern Med; 2012 Jun; 271(6):589-97. PubMed ID: 21950266
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
Amlani B; Elsayed G; Barvalia U; Kanne JP; Meyer KC; Sandbo N; Li Z; McCoy SS
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):136-147. PubMed ID: 33093777
[TBL] [Abstract][Full Text] [Related]
17. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease.
Bao Y; Zhang W; Shi D; Bai W; He D; Wang D
Int J Gen Med; 2021; 14():2553-2560. PubMed ID: 34163223
[TBL] [Abstract][Full Text] [Related]
19. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
[TBL] [Abstract][Full Text] [Related]
20. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]